+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Risk of vancomycin-resistant enterococci bloodstream infection among patients colonized with vancomycin-resistant enterococci



Risk of vancomycin-resistant enterococci bloodstream infection among patients colonized with vancomycin-resistant enterococci



Brazilian Journal of Infectious Diseases 19(1): 58-61



Vancomycin-resistant enterococci colonization has been reported to increase the risk of developing infections, including bloodstream infections. In this study, we aimed to share our experience with the vancomycin-resistant enterococci bloodstream infections following gastrointestinal vancomycin-resistant enterococci colonization in pediatric population during a period of 18 months. A retrospective cohort of children admitted to a 400-bed tertiary teaching hospital in Izmir, Turkey whose vancomycin-resistant enterococci colonization was newly detected during routine surveillances for gastrointestinal vancomycin-resistant enterococci colonization during the period of January 2009 and December 2012 were included in this study. All vancomycin-resistant enterococci isolates found within 18 months after initial detection were evaluated for evidence of infection. Two hundred and sixteen patients with vancomycin-resistant enterococci were included in the study. Vancomycin-resistant enterococci colonization was detected in 136 patients (62.3%) while they were hospitalized at intensive care units; while the remaining majority (33.0%) were hospitalized at hematology-oncology department. Vancomycin-resistant enterococci bacteremia was present only in three (1.55%) patients. All these patients were immunosuppressed due to human immunodeficiency virus (one patient) and intensive chemotherapy (two patients). In conclusion, our study found that 1.55% of vancomycin-resistant enterococci-colonized children had developed vancomycin-resistant enterococci bloodstream infection among the pediatric intensive care unit and hematology/oncology patients; according to our findings, we suggest that immunosupression is the key point for developing vancomycin-resistant enterococci bloodstream infections.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 058781185

Download citation: RISBibTeXText

PMID: 25529366

DOI: 10.1016/j.bjid.2014.09.010


Related references

Risk factors for development of vancomycin-resistant enterococcal bloodstream infection in patients with cancer who are colonized with vancomycin-resistant enterococci. Clinical Infectious Diseases 35(10): 1139-1146, 2002

Nosocomial vancomycin-resistant enterococcal blood stream infection development in oncology patients colonized with vancomycin-resistant enterococci. Clinical Infectious Diseases 31(1): 278, 2000

Possibility of vancomycin-resistant enterococci transmission from human to broilers, and possibility of using the vancomycin-resistant gram-positive cocci as a model in a screening study of vancomycin-resistant enterococci infection in the broiler chick. Animal Science Journal 77(5): 538-544, 2006

Antibiotic activity against urinary tract infection (UTI) isolates of vancomycin-resistant enterococci (VRE): results from the 2002 North American Vancomycin Resistant Enterococci Susceptibility Study (NAVRESS). Journal of Antimicrobial ChemoTherapy 52(3): 382-388, 2003

The effect of active surveillance for vancomycin-resistant enterococci in high-risk units on vancomycin-resistant enterococci incidence hospital-wide. American Journal of Infection Control 30(1): 40-43, 2002

Incidence of vancomycin-resistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VRE. Supportive Care in Cancer 19(2): 231-237, 2010

The interaction among infection control compliance, prevalence of colonized patients, and risk of spread of vancomycin-resistant enterococci. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 36: 219, 1996

Risk factors for vancomycin-resistant enterococci infection and mortality in colonized patients on intensive care unit admission. American Journal of Infection Control 40(10): 1018-1019, 2012

Clostridium difficile infection is a risk factor for bacteremia due to vancomycin-resistant enterococci (VRE) in VRE-colonized patients with acute leukemia. Clinical Infectious Diseases 25(5): 1056-1059, 1997

Low prevalence of patients colonized with vancomycin-resistant enterococci in spite of the high use of vancomycin. Abstracts of the General Meeting of the American Society for Microbiology 98: 190, 1998

Recurrent vancomycin-resistant Enterococcus faecium bacteremia in a leukemia patient who was persistently colonized with vancomycin-resistant enterococci for two years. Clinical Infectious Diseases 24(3): 514-515, 1997

A semiquantitative analysis of the fecal flora of patients with vancomycin-resistant enterococci: colonized patients pose an infection control risk. Clinical Infectious Diseases 25(4): 929-930, 1997

Colonization With Vancomycin-Resistant Enterococci and Risk for Bloodstream Infection Among Patients With Malignancy: A Systematic Review and Meta-Analysis. Open Forum Infectious Diseases 4(1): Ofw246, 2017

Near absence of vancomycin-resistant enterococci but high carriage rates of quinolone-resistant ampicillin-resistant enterococci among hospitalized patients and nonhospitalized individuals in Sweden. Journal of Clinical Microbiology 37(11): 3509-3513, 1999

A comparison of environmental contamination by patients infected or colonized with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a multicenter study. Infection Control and Hospital Epidemiology 35(7): 872-875, 2014